Exhibit 10.13.1

 

FOURTH AMENDMENT TO

LICENSE AND SERVICES AGREEMENT

 

This Fourth Amendment to License and Services Agreement (this
“Fourth Amendment”) is effective as of February 22, 2019 (the “Fourth Amendment
Effective Date”) by and between Axogen Corporation, a Delaware
corporation (“Licensee”) and Community Blood Center (d/b/a Community Tissue
Services), an Ohio corporation (“Licensor”).  Capitalized terms not otherwise
defined in this Fourth Amendment shall have the meaning as set forth in the
Agreement (defined below).

 

WHEREAS, on or about August 6, 2015 the parties entered into that certain
License and Services Agreement, as amended effective September 11, 2015 (“First
Amendment”), May 12, 2017 (“Second Amendment”), and May 19, 2017 (“Third
Amendment”) (collectively, the “Agreement”); and

 

WHEREAS, the parties desire to modify certain terms and conditions of the
Agreement as more fully set forth below.

 

NOW, THEREFORE, in consideration of the mutual promises contained herein and
other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, Licensor and Licensee intending to be legally bound agree
as follows:

 

1.     Term Extension.   Section 12.01 of the Agreement is hereby deleted in its
entirety and replaced with the following:

 

“12.01 Term.  Unless otherwise terminated pursuant to the terms of this
Agreement, the License granted hereunder shall commence on the Occupancy Date
and shall end on December 31, 2021.”

 

2.     Termination.  Section 12.02(d) of the Agreement is hereby deleted in its
entirety and replaced with the following:

 

“(d) Other than as provided in Section 12.02 (a) and (b), and through February
28,  2021, neither party shall terminate this Agreement.  Effective and
beginning March 1, 2021,  Licensee may terminate this Agreement upon providing
six (6) months written notice of termination to Licensor.”

 

3.     Fee Adjustment.    Section 3 of Schedule II “Fees” of the Agreement is
hereby deleted in its entirety and replaced with the following as of the
Effective Date of this Fourth Amendment: 

 

“In addition to adjustments under the circumstances described in Section 4.01,
the Support Service Fees shall increase by three percent (3%) on each January
1st during the Term.  Effective September 1, 2020, the License Fee shall
increase on a one-time basis by an additional twenty percent (20%).  

 

4.     Option for Additional Clean Room.  The parties acknowledge that Clean
Room No. M423 is currently part of Licensee’s Option Space (the “Available Clean
Room”).  As of June 1, 2020, and upon nine (9) months advanced written notice to
Licensor, Licensee shall have the exclusive option to add the Available Clean
Room to the Licensed Space and shall owe Licensor such additional fees as
provided pursuant to Schedule II to the Agreement, as amended, for the
additional Licensed Space.  The parties rights in the Agreement with respect to
other Option Space, CTS Option Space or Reserved Space remain unaffected except
to the extent amended herein with regard to the Available Clean Room.

 

5.     Portland Recovery.    Licensee shall prioritize its procurement of
nerves from CTS Portland above all other sources in an effort to ensure that CTS
Portland maintains at least the same volume as recorded in 2018, and no less
than 76 annually.  

1

--------------------------------------------------------------------------------

 

6.     Full Force and Effect.  With the modifications set forth in this
Fourth Amendment, the Agreement remains in full force and effect.

 

7.     Miscellaneous:  This Fourth Amendment may be executed in one or more
counterparts, each of which shall be deemed an original of this Fourth Amendment
and all of which, when taken together, shall be deemed to constitute one and the
same valid and binding Fourth Amendment.  This Fourth Amendment may be
transmitted by facsimile or in .pdf electronic format, and it is the intent of
the parties that any signature printed by a receiving facsimile machine or
computer system to be deemed an original signature.

 

IN WITNESS WHEREOF, the parties hereto have duly executed this Fourth Amendment
as of the Fourth Amendment Effective Date.

 

COMMUNITY BLOOD CENTER

    

AXOGEN CORPORATION

D/B/A COMMUNITY TISSUE SERVICES

 

 

 

 

 

 

 

 

By:

/s/Diane Wilson

 

By:

/s/ Karen Zaderej

Name:

Diane Wilson

 

Name:

Karen Zaderej

Title:

COO 2/20/19

 

Title:

President and CEO 2/22/19

 

2

--------------------------------------------------------------------------------